Keyphrases
Cross-neutralization
100%
Zika Virus
100%
Cross-protection
100%
E Protein Domain III
100%
Neutralizing Antibodies
40%
Zika Virus Infection
40%
Virus Strains
40%
Lethal Challenge
20%
Fetus
10%
Subunit Vaccine
10%
Specific Antibodies
10%
Birth Defects
10%
High Titer
10%
Passive Immunization
10%
Interferon Receptor
10%
Recombinant Protein
10%
Human Use
10%
Passive Transfer
10%
Human IgG
10%
Microcephaly
10%
Immunogenicity
10%
Pregnant Women
10%
Colombia
10%
Envelope (E) Protein
10%
Virus Envelope
10%
Mouse Serum
10%
Congenital Zika Syndrome
10%
Honduras
10%
Host Country
10%
Health Threat
10%
Immunocompromised Adults
10%
AG129 Mice
10%
Immunology and Microbiology
Neutralization
100%
Zika Virus
100%
Protein Tertiary Structure
100%
Neutralizing Antibody
28%
Viral Disease
28%
Virus Strain
28%
interferon
7%
Titer
7%
Subunit Vaccine
7%
Carboxy Terminal Sequence
7%
Immunogenicity
7%
Viral Envelope
7%
Infection
7%
Pharmacology, Toxicology and Pharmaceutical Science
Zika Virus
100%
Neutralizing Antibody
40%
Zika Fever
40%
Virus Strain
40%
Infection
10%
Syndrome
10%
Interferon Receptor
10%
Congenital Malformation
10%
Immunogenicity
10%
Recombinant Protein
10%
Microcephaly
10%
Subunit Vaccine
10%